Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.27x is 84% above its 2-year average of -13.91x, near the high end of its 2-year range (-53.66x–-0.30x).
80.18% above its 12-month average of -11.45x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -1.03x.
INTEREST COVERAGE RATIO
-2.27x
INTEREST COVERAGE RATIO AVG TTM
-11.45x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+80.18%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 323 covered companies
CURRENT VS SECTOR MEDIAN
+45.95%
vs the sector median at left
Aspire Biopharma Holdings, Inc.
Market Cap
$1.02M
Interest Coverage Ratio
-2.27x
TTM Avg
-11.45x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11M
Interest Coverage Ratio
-290.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14M
Interest Coverage Ratio
-7.46x
TTM Avg
10.39x
3Y Avg
21.90x
5Y Avg
21.90x
Market Cap
$888387.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$885939.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
Market Cap
$878396.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.17M
Interest Coverage Ratio
-4.20x
TTM Avg
1.01x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$1.17M
Interest Coverage Ratio
-134.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$787624.00
Interest Coverage Ratio
-8287.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.02M | -2.27x | -11.45x | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -290.08x | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -7.46x | 10.39x | 21.90x | 21.90x |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | 354.05x | 372.60x | 299.52x |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -4.20x | 1.01x | 1.00x | 1.00x |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.17M | -134.94x | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | -8287.21x | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $707297.00 | -115.23x | N/A | N/A | N/A |
Interest Coverage
-2.3x
Debt/Equity
0.00
Current Ratio
7.99
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -1.03x |
| 2025-12-31 | -0.30x |
| 2025-09-30 | -0.77x |
| 2025-06-30 | -1.52x |
| 2025-03-31 | -53.66x |
| 2024-12-31 | -6.81x |
| 2024-06-30 | -2.41x |
| 2024-03-31 | -13.76x |
| 2023-12-31 | -44.90x |
